ODI Pharma AB (publ) (NGM:ODI)
Sweden
· Delayed Price · Currency is SEK 4.060
-0.060 (-1.46%)
At close: Mar 9, 2026
ODI Pharma AB Revenue
ODI Pharma AB had revenue of 10.93M SEK in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 20.04M, down -6.80% year-over-year. In the fiscal year ending June 30, 2025, ODI Pharma AB had annual revenue of 3.13M, down -85.94%.
Revenue (ttm)
20.04M
Revenue Growth
-6.80%
P/S Ratio
3.77
Revenue / Employee
20.04M
Employees
1
Market Cap
75.52M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ramlösa shipping AB | 39.85M |
| Mediacle Group AB | 47.81M |
| Railway Metrics and Dynamics Sweden AB | 13.62M |
| Coegin Pharma AB | 79.00K |
| Lohilo Foods AB | 186.79M |
| Spotlight Group AB | 114.42M |
| Katalysen Ventures AB | 1.65M |
| NGS Group AB | 285.72M |